Human Immune System (HIS) and Patient-Derived Xenograft (PDX) models

Feb 14, 2020 11:21:11 AM / by Champions Oncology posted in Humanized Models

ImmunoGraft

Champions Oncology and others in the field working with patient derived xenografts (PDX) are developing and providing translationally relevant preclinical models to test therapeutic efficacy of IO agents as monotherapy or rational combinations in humanized mice engrafted with functional human immune system.

Read More →
Content not found